DAVENPORT & Co LLC Purchases 27,589 Shares of iShares Biotechnology ETF $IBB

DAVENPORT & Co LLC grew its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 185.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 42,428 shares of the financial services provider’s stock after acquiring an additional 27,589 shares during the quarter. DAVENPORT & Co LLC owned 0.08% of iShares Biotechnology ETF worth $7,161,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. BNP Paribas Financial Markets lifted its position in shares of iShares Biotechnology ETF by 313.2% in the third quarter. BNP Paribas Financial Markets now owns 1,915,395 shares of the financial services provider’s stock worth $276,526,000 after purchasing an additional 1,451,820 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in iShares Biotechnology ETF by 27.2% during the third quarter. JPMorgan Chase & Co. now owns 1,060,048 shares of the financial services provider’s stock worth $153,039,000 after purchasing an additional 226,852 shares during the last quarter. Jefferies Financial Group Inc. acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $65,083,000. Barclays PLC increased its stake in iShares Biotechnology ETF by 6.7% in the 3rd quarter. Barclays PLC now owns 416,191 shares of the financial services provider’s stock valued at $60,085,000 after buying an additional 26,032 shares during the last quarter. Finally, Focus Partners Wealth lifted its position in iShares Biotechnology ETF by 8.8% during the 3rd quarter. Focus Partners Wealth now owns 116,844 shares of the financial services provider’s stock worth $16,878,000 after buying an additional 9,404 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $165.38 on Friday. The firm has a 50-day moving average of $171.36 and a 200-day moving average of $163.94. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were issued a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.